We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Targets Early Instigator of Alzheimer's Disease

News   Aug 15, 2019 | Original story from Arizona State University

 
Drug Targets Early Instigator of Alzheimer's Disease

DYR219 is a powerful new drug developed by Travis Dunckley and his colleagues and described in the new study. Its strength lies in the fact that it can target both of the leading pathologies associated with Alzheimer's disease--plaques, (caused by the protein amyloid beta) and tangles, (caused by the tau protein). Credit: Graphic by Shireen Dooling

 
 
 

RELATED ARTICLES

Yoga Makes Same Changes As Aerobic Exercise in the Brain

News

Scientists have known for decades that aerobic exercise strengthens the brain and contributes to the growth of new neurons, but few studies have examined how yoga affects the brain. A review of the science finds evidence that yoga enhances many of the same brain structures and functions that benefit from aerobic exercise.

READ MORE

Therapeutic Exosomes Go From Vein to Brain

News

A team of researchers from the University of Georgia's Regenerative Bioscience Center has found that neural exosomes--"cargo" molecules within the nervous system that carry messages to the brain--can minimize or even avert progression of traumatic brain injury when used as part of a new cell-to-cell messaging technology.

READ MORE

ME and Chronic Fatigue Syndrome Linked to Immune Cell Changes

News

Research suggests that there are changes in the immune system of myalgic encephalomyelitis (ME) and chronic fatigue syndrome sufferes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE